Results 111 to 120 of about 409,422 (240)

Malignant Mesothelioma of the Pericardium: A Report of Two Different Presentations

Case Reports in Oncological Medicine, 2013
Malignant mesothelioma of the pericardium is a rare and fatal condition that clinicians should be aware of due to its variability of clinical manifestation. The diagnosis may be delayed as a result of delayed treatment.
Pattarapong Makarawate, Narumol Chaosuwannakit, Jarin Chindaprasirt, Piti Ungarreevittaya, Surachat Chaiwiriyakul, Kosin Wirasorn, Chusak Kuptarnond, Kittisak Sawanyawisuth   +7 more
doaj   +1 more source

Incidence, Clinical Characteristics, Management, and Outcomes of Hematologic Immune‐Related Adverse Events Associated With Immune Checkpoint Inhibitors: A Single‐Center Japanese Retrospective Cohort Study

Cancer Medicine, Volume 15, Issue 10, October 2026.
This single‐center retrospective study evaluated hematologic immune‐related adverse events (irAEs) among 3371 patients treated with immune checkpoint inhibitors. Forty patients developed hematologic irAEs (1.2%); 85.0% of events were Grade 3 or higher, and the median time to onset was 12 weeks.
Ryo Yoshimaru, Hirotaka Nakamura, Yong‐Mei Guo, Kensuke Matsuda, Tetsuya Sakai, Yoshitaka Zenke, Kiyotaka Yoh, Kohei Shitara, Nobuaki Matsubara, Kenichi Harano, Hiromichi Nakajima, Nobuyuki Takahashi, Masafumi Ikeda, Takao Fujisawa, Saki Nakamura, Kenta Akie, Masayuki Ito, Masashi Wakabayashi, Junichiro Yuda   +18 more
wiley   +1 more source

Diffuse malignant peritoneal mesothelioma

, 2013
Mesothelioma often originates in the pleura and less frequently in the peritoneum. This article describes a rare case of diffuse malignant peritoneal mesothelioma in a 54-year-old male construction worker who was admitted to our hospital with a 2-month ...
Chih-An Shih, Szu-Pei Ho, Kwok-Hung Lai, Ping-I Hsu, Feng-Woei Tsay   +4 more
core   +1 more source

Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background The development of cancer treatments relies on patient participation in clinical trials, yet poor recruitment and retention hinder evidence generation. There exists an urgent need for trial designs that address patient‐identified barriers, informational gaps, and concerns. The goal of this evidence synthesis was to identify patient‐
Sarah Scruton, Chisato Ito, Julia Bohnen, Robin Urquhart, Chiquita Hessels, Summer Konechny, Rosilene Kraft, Randy Thompson, Cheryl Ho, Deirdre Weymann, Yvonne Bombard, Emanuel Krebs, Avram Denburg, Timothy P. Hanna, Howard J. Lim, Saadia Shareen, Dean A. Regier, Samantha Pollard   +17 more
wiley   +1 more source

Malignant Mesothelioma of Tunica Vaginalis

, 2004
Mesothelioma is often diagnosed as a malignant scrotal mass without pain or inflammatory signs. It is a very rare tumor with quite uncommon sites of involvement.
H Mazdak, M Mokhtari
core  

Malignant Mesothelioma

Siriraj Medical Journal, 2002
A 27 year old Thai male presented with progressive abdominal distension without leg edema, low grade fever and 10 Kgs weight loss over 2 months.
Phunchai Charuscharoenwitthaya, Cherdsak Iramaneerat, Ranista Suchato, Soranat Muangsomboon   +3 more
doaj  

Integrative Bioinformatics and Machine Learning Approaches for Biomarker and Pathway Discovery in Malignant Pleural Mesothelioma

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Malignant pleural mesothelioma (MPM) is a highly aggressive thoracic cancer with limited treatment options and poor prognosis. Aims This study employed an integrative transcriptomic and computational approach to uncover potential biomarkers for MPM.
Md. Lotifur Rohman, Suman Biswas
wiley   +1 more source

Chemosensitivity and Cytokine Sensitivity of Malignant Mesothelioma

, 1991
Malignant mesothelioma arises in serosal tissues, is locally invasive, and is usually resistant to chemotherapeutic agents used clinically. To determine whether resistance to cytotoxic drugs was an inherent characteristic of mesothelioma cells, we ...
Manning, LS, Davis, MR, Bowman, RV, Robinson, Bws   +3 more
core   +1 more source

Brain Metastases With Malignant Peritoneal Mesothelioma: Never Reported Before.

, 2023
Malignant mesothelioma is a very rare diagnosis. Malignant mesotheliomas arise from surface linings of pleura, peritoneal cavity, or tunica vaginalis and pericardium with pleural malignant mesotheliomas being the most common.
Adeel, Waqas, Misiura, Merissa, MD, Tariq, Rizwan, MD, Lal, Darshan, MD   +3 more
core   +1 more source

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change

International Journal of Cancer, Volume 159, Issue 7, Page 1588-1601, 1 October 2026.
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley, Liesbet J. Van Eycken, Meredith E. Giuliani, Brian A. Rous, Shao Hui Huang, Hisao Asamura, Mary K. Gospodarowicz, Anne W. Lee, Brian O'Sullivan   +8 more
wiley   +1 more source